Protein Microarrays: Valuable Tools for Ocular Diseases Research

Curr Med Chem. 2020;27(27):4549-4566. doi: 10.2174/0929867326666190627131300.

Abstract

The eye is a complex organ comprised of several compartments with exclusive and specialized properties that reflect their diverse functions. Although the prevalence of eye pathologies is increasing, mainly because of its correlation with aging and of generalized lifestyle changes, the pathogenic molecular mechanisms of many common ocular diseases remain poorly understood. Therefore, there is an unmet need to delve into the pathogenesis, diagnosis, and treatment of eye diseases to preserve ocular health and reduce the incidence of visual impairment or blindness. Proteomics analysis stands as a valuable tool for deciphering protein profiles related to specific ocular conditions. In turn, such profiles can lead to real breakthroughs in the fields of ocular science and ophthalmology. Among proteomics techniques, protein microarray technology stands out by providing expanded information using very small volumes of samples. In this review, we present a brief summary of the main types of protein microarrays and their application for the identification of protein changes in chronic ocular diseases such as dry eye, glaucoma, age-related macular degeneration, or diabetic retinopathy. The validation of these specific protein alterations could provide new biomarkers, disclose eye diseases pathways, and help in the diagnosis and development of novel therapies for eye pathologies.

Keywords: Protein microarrays; age-related macular degeneration; diabetic retinopathy; dry eye; glaucoma; ocular pathology.

Publication types

  • Review

MeSH terms

  • Diabetic Retinopathy
  • Eye
  • Eye Diseases*
  • Glaucoma
  • Humans
  • Macular Degeneration
  • Protein Array Analysis